位置:首页 > 蛋白库 > DPOD1_MOUSE
DPOD1_MOUSE
ID   DPOD1_MOUSE             Reviewed;        1105 AA.
AC   P52431; O54883; Q3TFX6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 177.
DE   RecName: Full=DNA polymerase delta catalytic subunit {ECO:0000305};
DE            EC=2.7.7.7 {ECO:0000250|UniProtKB:P28340};
DE   AltName: Full=3'-5' exodeoxyribonuclease {ECO:0000305};
DE            EC=3.1.11.- {ECO:0000250|UniProtKB:P28340};
GN   Name=Pold1 {ECO:0000312|MGI:MGI:97741};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ;
RX   PubMed=8262377; DOI=10.1016/0378-1119(93)90093-i;
RA   Cullmann G., Hindges R., Berchtold M.W., Huebscher U.;
RT   "Cloning of a mouse cDNA encoding DNA polymerase delta: refinement of the
RT   homology boxes.";
RL   Gene 134:191-200(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=129/SvJ;
RX   PubMed=9434960; DOI=10.1007/s003359900693;
RA   Goldsby R.E., Singh M., Preston B.D.;
RT   "Mouse DNA polymerase delta gene (Pold1) maps to chromosome 7.";
RL   Mamm. Genome 9:92-93(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Heart, and Liver;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   PROTEIN SEQUENCE OF 408-415, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=OF1; TISSUE=Hippocampus;
RA   Lubec G., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Liver, Lung, Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: As the catalytic component of the trimeric (Pol-delta3
CC       complex) and tetrameric DNA polymerase delta complexes (Pol-delta4
CC       complex), plays a crucial role in high fidelity genome replication,
CC       including in lagging strand synthesis, and repair. Exhibits both DNA
CC       polymerase and 3'- to 5'-exonuclease activities. Requires the presence
CC       of accessory proteins POLD2, POLD3 and POLD4 for full activity.
CC       Depending upon the absence (Pol-delta3) or the presence of POLD4 (Pol-
CC       delta4), displays differences in catalytic activity. Most notably,
CC       expresses higher proofreading activity in the context of Pol-delta3
CC       compared with that of Pol-delta4. Although both Pol-delta3 and Pol-
CC       delta4 process Okazaki fragments in vitro, Pol-delta3 may be better
CC       suited to fulfill this task, exhibiting near-absence of strand
CC       displacement activity compared to Pol-delta4 and stalling on encounter
CC       with the 5'-blocking oligonucleotides. Pol-delta3 idling process may
CC       avoid the formation of a gap, while maintaining a nick that can be
CC       readily ligated. Along with DNA polymerase kappa, DNA polymerase delta
CC       carries out approximately half of nucleotide excision repair (NER)
CC       synthesis following UV irradiation. Under conditions of DNA replication
CC       stress, in the presence of POLD3 and POLD4, may catalyze the repair of
CC       broken replication forks through break-induced replication (BIR).
CC       Involved in the translesion synthesis (TLS) of templates carrying O6-
CC       methylguanine, 8oxoG or abasic sites. {ECO:0000250|UniProtKB:P28340}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.7;
CC         Evidence={ECO:0000250|UniProtKB:P28340};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; Evidence={ECO:0000250};
CC       Note=Binds 1 [4Fe-4S] cluster. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Regulated by alteration of quaternary structure.
CC       Exhibits burst rates of DNA synthesis are about 5 times faster in the
CC       presence of POLD4 (Pol-delta4 complex) than in its absence (Pol-delta3
CC       complex), while the affinity of the enzyme for its DNA and dNTP
CC       substrates appears unchanged. The Pol-delta3 complex is more likely to
CC       proofread DNA synthesis because it cleaves single-stranded DNA twice as
CC       fast and transfers mismatched DNA from the polymerase to the
CC       exonuclease sites 9 times faster compared to the Pol-delta3 complex.
CC       Pol-delta3 also extends mismatched primers 3 times more slowly in the
CC       absence of POLD4. The conversion of Pol-delta4 into Pol-delta3 is
CC       induced by genotoxic stress or by replication stress leading POLD4
CC       degradation. Stimulated in the presence of PCNA (By similarity). This
CC       stimulation is further increased in the presence of KCTD13/PDIP1, most
CC       probably via direct interaction between KCTD13 and POLD2 (By
CC       similarity). {ECO:0000250|UniProtKB:P28339,
CC       ECO:0000250|UniProtKB:P28340}.
CC   -!- SUBUNIT: Component of the tetrameric DNA polymerase delta complex (Pol-
CC       delta4), which consists of POLD1/p125, POLD2/p50, POLD3/p66/p68 and
CC       POLD4/p12, with POLD1 bearing both DNA polymerase and 3' to 5'
CC       proofreading exonuclease activities. Within Pol-delta4, directly
CC       interacts with POLD2 and POLD4. Following genotoxic stress by DNA-
CC       damaging agents, such as ultraviolet light and methyl methanesulfonate,
CC       or by replication stress induced by treatment with hydroxyurea or
CC       aphidicolin, Pol-delta4 is converted into a trimeric form of the
CC       complex (Pol-delta3) by POLD4 degradation. Pol-delta3 is the major form
CC       at S phase replication sites and DNA damage sites. POLD1 displays
CC       different catalytic properties depending upon the complex it is found
CC       in. It exhibits higher proofreading activity and fidelity than Pol-
CC       delta4, making it particularly well suited to respond to DNA damage.
CC       Directly interacts with PCNA, as do POLD3 and POLD4; this interaction
CC       stimulates Pol-delta4 polymerase activity. As POLD2 and POLD4, directly
CC       interacts with WRNIP1; this interaction stimulates DNA polymerase
CC       delta-mediated DNA synthesis, independently of the presence of PCNA.
CC       This stimulation may be due predominantly to an increase of initiation
CC       frequency and also to increased processivity. Also observed as a
CC       dimeric complex with POLD2 (Pol-delta2). Pol-delta2 is relatively
CC       insensitive to the PCNA stimulation (2-5-fold) compared to Pol-delta4
CC       that is stimulated by over 50-fold. The DNA polymerase delta complex
CC       interacts with POLDIP2; this interaction is probably mediated through
CC       direct binding to POLD2. Interacts with CIAO1. Interacts with POLDIP2
CC       (By similarity). {ECO:0000250|UniProtKB:P28340}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P28340}.
CC       Note=Colocalizes with PCNA and POLD3 at S phase replication sites.
CC       After UV irradiation, recruited to DNA damage sites within 2 hours,
CC       independently on the cell cycle phase, nor on PCNA ubiquitination. This
CC       recruitment requires POLD3, PCNA and RFC1-replication factor C complex.
CC       {ECO:0000250|UniProtKB:P28340}.
CC   -!- DOMAIN: The CysB motif binds 1 4Fe-4S cluster and is required for the
CC       formation of polymerase complexes. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-B family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z21848; CAA79895.1; -; mRNA.
DR   EMBL; AF024570; AAB99910.1; -; Genomic_DNA.
DR   EMBL; AK167569; BAE39632.1; -; mRNA.
DR   EMBL; AK168967; BAE40772.1; -; mRNA.
DR   EMBL; AK169040; BAE40829.1; -; mRNA.
DR   CCDS; CCDS21210.1; -.
DR   PIR; S40243; S40243.
DR   RefSeq; NP_035261.3; NM_011131.3.
DR   AlphaFoldDB; P52431; -.
DR   SMR; P52431; -.
DR   BioGRID; 202290; 6.
DR   ComplexPortal; CPX-2098; DNA polymerase delta complex.
DR   CORUM; P52431; -.
DR   DIP; DIP-45885N; -.
DR   IntAct; P52431; 2.
DR   STRING; 10090.ENSMUSP00000039776; -.
DR   iPTMnet; P52431; -.
DR   PhosphoSitePlus; P52431; -.
DR   EPD; P52431; -.
DR   MaxQB; P52431; -.
DR   PaxDb; P52431; -.
DR   PeptideAtlas; P52431; -.
DR   PRIDE; P52431; -.
DR   ProteomicsDB; 277387; -.
DR   Antibodypedia; 3821; 369 antibodies from 37 providers.
DR   DNASU; 18971; -.
DR   Ensembl; ENSMUST00000049343; ENSMUSP00000039776; ENSMUSG00000038644.
DR   GeneID; 18971; -.
DR   KEGG; mmu:18971; -.
DR   UCSC; uc009gpx.2; mouse.
DR   CTD; 5424; -.
DR   MGI; MGI:97741; Pold1.
DR   VEuPathDB; HostDB:ENSMUSG00000038644; -.
DR   eggNOG; KOG0969; Eukaryota.
DR   GeneTree; ENSGT00560000077365; -.
DR   HOGENOM; CLU_000203_2_0_1; -.
DR   InParanoid; P52431; -.
DR   OMA; GNQKSPY; -.
DR   OrthoDB; 20210at2759; -.
DR   PhylomeDB; P52431; -.
DR   TreeFam; TF352785; -.
DR   Reactome; R-MMU-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-MMU-174411; Polymerase switching on the C-strand of the telomere.
DR   Reactome; R-MMU-174414; Processive synthesis on the C-strand of the telomere.
DR   Reactome; R-MMU-174417; Telomere C-strand (Lagging Strand) Synthesis.
DR   Reactome; R-MMU-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-MMU-5358565; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   Reactome; R-MMU-5358606; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta).
DR   Reactome; R-MMU-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-MMU-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-MMU-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-MMU-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-MMU-5696400; Dual Incision in GG-NER.
DR   Reactome; R-MMU-6782135; Dual incision in TC-NER.
DR   Reactome; R-MMU-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-MMU-69091; Polymerase switching.
DR   Reactome; R-MMU-69166; Removal of the Flap Intermediate.
DR   Reactome; R-MMU-69183; Processive synthesis on the lagging strand.
DR   BioGRID-ORCS; 18971; 54 hits in 109 CRISPR screens.
DR   ChiTaRS; Pold1; mouse.
DR   PRO; PR:P52431; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; P52431; protein.
DR   Bgee; ENSMUSG00000038644; Expressed in optic fissure and 248 other tissues.
DR   ExpressionAtlas; P52431; baseline and differential.
DR   Genevisible; P52431; MM.
DR   GO; GO:0016235; C:aggresome; ISO:MGI.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0043625; C:delta DNA polymerase complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0000109; C:nucleotide-excision repair complex; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0008408; F:3'-5' exonuclease activity; IMP:MGI.
DR   GO; GO:0008296; F:3'-5'-exodeoxyribonuclease activity; IBA:GO_Central.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISO:MGI.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; ISO:MGI.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0006287; P:base-excision repair, gap-filling; IMP:MGI.
DR   GO; GO:0034644; P:cellular response to UV; ISS:UniProtKB.
DR   GO; GO:0071897; P:DNA biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; ISO:MGI.
DR   GO; GO:0045004; P:DNA replication proofreading; IMP:MGI.
DR   GO; GO:0000731; P:DNA synthesis involved in DNA repair; ISS:UniProtKB.
DR   GO; GO:0006261; P:DNA-templated DNA replication; ISO:MGI.
DR   GO; GO:0070987; P:error-free translesion synthesis; ISS:UniProtKB.
DR   GO; GO:0055089; P:fatty acid homeostasis; ISS:UniProtKB.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; ISO:MGI.
DR   Gene3D; 1.10.132.60; -; 1.
DR   Gene3D; 3.30.420.10; -; 1.
DR   Gene3D; 3.90.1600.10; -; 2.
DR   InterPro; IPR006172; DNA-dir_DNA_pol_B.
DR   InterPro; IPR017964; DNA-dir_DNA_pol_B_CS.
DR   InterPro; IPR006133; DNA-dir_DNA_pol_B_exonuc.
DR   InterPro; IPR006134; DNA-dir_DNA_pol_B_multi_dom.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR042087; DNA_pol_B_thumb.
DR   InterPro; IPR023211; DNA_pol_palm_dom_sf.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   InterPro; IPR025687; Znf-C4pol.
DR   Pfam; PF00136; DNA_pol_B; 1.
DR   Pfam; PF03104; DNA_pol_B_exo1; 1.
DR   Pfam; PF14260; zf-C4pol; 1.
DR   PRINTS; PR00106; DNAPOLB.
DR   SMART; SM00486; POLBc; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   SUPFAM; SSF56672; SSF56672; 1.
DR   PROSITE; PS00116; DNA_POLYMERASE_B; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Direct protein sequencing; DNA damage; DNA excision; DNA repair;
KW   DNA replication; DNA-binding; DNA-directed DNA polymerase; Exonuclease;
KW   Hydrolase; Iron; Iron-sulfur; Isopeptide bond; Metal-binding; Methylation;
KW   Nuclease; Nucleotidyltransferase; Nucleus; Reference proteome; Transferase;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1105
FT                   /note="DNA polymerase delta catalytic subunit"
FT                   /id="PRO_0000046444"
FT   ZN_FING         1010..1027
FT                   /note="CysA-type"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           4..19
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1056..1074
FT                   /note="CysB motif"
FT   BINDING         1010
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         1013
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         1024
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         1027
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         1056
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000250"
FT   BINDING         1059
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000250"
FT   BINDING         1069
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000250"
FT   BINDING         1074
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         19
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P28340"
FT   CROSSLNK        572
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P28340"
FT   CONFLICT        112
FT                   /note="G -> R (in Ref. 1; CAA79895)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114
FT                   /note="L -> P (in Ref. 2; AAB99910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        576
FT                   /note="S -> G (in Ref. 1; CAA79895 and 2; AAB99910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        793
FT                   /note="E -> K (in Ref. 2; AAB99910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1000
FT                   /note="L -> F (in Ref. 2; AAB99910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1035
FT                   /note="Y -> S (in Ref. 1; CAA79895)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1045..1052
FT                   /note="LEERFSRL -> WKNGSLRF (in Ref. 2; AAB99910)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1105 AA;  123790 MW;  2AE377D42E3A6A86 CRC64;
     MDCKRRQGPG PGVPPKRARG HLWDEDEPSP SQFEANLALL EEIEAENRLQ EAEEELQLPP
     EGTVGGQFST ADIDPRWRRP TLRALDPSTE PLIFQQLEID HYVGSAPPLP EGPLPSRNSV
     PILRAFGVTD EGFSVCCHIQ GFAPYFYTPA PPGFGAEHLS ELQQELNAAI SRDQRGGKEL
     SGPAVLAIEL CSRESMFGYH GHGPSPFLRI TLALPRLMAP ARRLLEQGVR VPGLGTPSFA
     PYEANVDFEI RFMVDADIVG CNWLELPAGK YVRRAEKKAT LCQLEVDVLW SDVISHPPEG
     QWQRIAPLRV LSFDIECAGR KGIFPEPERD PVIQICSLGL RWGEPEPFLR LALTLRPCAP
     ILGAKVQSYE REEDLLQAWA DFILAMDPDV ITGYNIQNFD LPYLISRAQA LKVDRFPFLG
     RVTGLRSNIR DSSFQSRQVG RRDSKVISMV GRVQMDMLQV LLREHKLRSY TLNAVSFHFL
     GEQKEDVQHS IITDLQNGNE QTRRRLAVYC LKDAFLPLRL LERLMVLVNN VEMARVTGVP
     LGYLLTRGQQ VKVVSQLLRQ AMRQGLLMPV VKTEGSEDYT GATVIEPLKG YYDVPIATLD
     FSSLYPSIMM AHNLCYTTLL RPGAAQKLGL KPDEFIKTPT GDEFVKSSVR KGLLPQILEN
     LLSARKRAKA ELAQETDPLR RQVLDGRQLA LKVSANSVYG FTGAQVGKLP CLEISQSVTG
     FGRQMIEKTK QLVESKYTVE NGYDANAKVV YGDTDSVMCR FGVSSVAEAM SLGREAANWV
     SSHFPSPIRL EFEKVYFPYL LISKKRYAGL LFSSRSDAHD KMDCKGLEAV RRDNCPLVAN
     LVTSSLRRIL VDRDPDGAVA HAKDVISDLL CNRIDISQLV ITKELTRAAA DYAGKQAHVE
     LAERMRKRDP GSAPSLGDRV PYVIIGAAKG VAAYMKSEDP LFVLEHSLPI DTQYYLEQQL
     AKPLLRIFEP ILGEGRAESV LLRGDHTRCK TVLTSKVGGL LAFTKRRNCC IGCRSVIDHQ
     GAVCKFCQPR ESELYQKEVS HLNALEERFS RLWTQCQRCQ GSLHEDVICT SRDCPIFYMR
     KKVRKDLEDQ ERLLQRFGPP GPEAW
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025